Adverse effects from counterfeit and mislabeled medicine containing tapentadol and carisoprodol

Gitte Plæhn, Thomas Fuglsang, Peter Hindersson, Torben Breindahl*

*Corresponding author for this work

Research output: Contribution to journalCase ReportResearchpeer-review

124 Downloads (Pure)

Abstract

When self-administration with counterfeit or mislabeled medicine is suspected, comprehensive laboratory analysis should be preferred over immunoassay screening to avoid false negative results. Carisoprodol, which was formerly a popular muscle relaxant drug in many countries, has reappeared on illegal drug markets, and may cause an itching, purple-colored rash, even after a single dose.

Original languageEnglish
Article numbere9241
JournalClinical Case Reports
Volume12
Issue number8
Number of pages6
ISSN2050-0904
DOIs
Publication statusPublished - Aug 2024

Bibliographical note

© 2024 The Author(s). Clinical Case Reports published by John Wiley & Sons Ltd.

Fingerprint

Dive into the research topics of 'Adverse effects from counterfeit and mislabeled medicine containing tapentadol and carisoprodol'. Together they form a unique fingerprint.

Cite this